Projects per year
Search results
-
Active
Targeting CD83 to reduce leukemia relapse and GVHD after allogeneic hematopoietic cell transplantation
Betts, B., Holtan, S. G. & Linden, M. A.
NIH NAT'L HEART, LUNG, AND BLOOD INSTITU
4/1/23 → 2/29/28
Project: Research project
-
PTCy + Sirolimus/VIC-1911 as GVHD prophylaxis in myeloablative PBSC transplantation
8/20/21 → 8/31/26
Project: Research project
-
AGAVE-201, A Phase 2, Open-label, Randomized, MulticenterStudy to Evaluate the Efficacy, Safety and Tolerability ofAxatilimab at 3 Different Doses in Patients with Recurrent orRefractory Active Chronic Graft Versus Host Disease who haveReceived at le
Holtan, S. G. & Arora, M.
11/1/20 → 10/31/25
Project: Research project
-
Neoadjuvant therapy for patients with high risk stage III melanoma
Kratzke, R. A., Domingo-Musibay, E. & Holtan, S. G.
MAYO CLINIC ROCHESTER, AMERICAN ASSOCIATION FOR CANCER RESEARCH
6/1/18 → 11/30/24
Project: Research project
-
Single Arm Phase II Study of Ipilimumab and Nivolumab as
Kratzke, R. A., Domingo-Musibay, E. & Holtan, S. G.
BIG TEN CANCER RESEARCH CONSORTIUM, BRISTOL-MYERS SQUIBB COMPANY
12/1/17 → 3/31/25
Project: Research project
-
ALT-803 (IL-15/IL-15Ra-Fc) maintenance after allogeneic
Holtan, S. G., Arora, M., Wagner, J. E., Brunstein, C. G. & Weisdorf, D. J.
NIH NAT'L HEART, LUNG, AND BLOOD INSTITU
7/26/17 → 6/30/24
Project: Research project
-
ALT-803 (IL-15/IL-15Rα-Fc) maintenance after allogeneic transplantation for AML
Holtan, S. G., Brunstein, C. G. & Weisdorf, D. J.
National Heart, Lung, and Blood Institute
7/26/17 → 6/30/24
Project: Research project